Evonetix unveils new branding to align with its vision for gene-length DNA synthesis Post author: Post published:October 2, 2023 Post category:uncategorized EVONETIX LTD (‘Evonetix’) today announces the introduction of new branding. You Might Also Like New dual-chamber wireless pacemaker shows reliable performance in clinical trial July 30, 2024 Disruption of smoking cessation medicine linked to avoidable deaths April 30, 2024 Improved animal model captures full picture of periodontal disease progression May 22, 2024